public offering of stock

ATLANTA, Jan. 9, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (BOTA) ("Biota" or the "Company") today announced its intention, subject to market and other conditions, to commence a public offering of its common stock. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

Guggenheim Securities, LLC is acting as sole book-running manager of the offering. The offering is being made pursuant to a shelf registration statement previously filed with the Securities and Exchange Commission ("SEC") and declared effective on October 17, 2013. A preliminary prospectus supplement relating to the offering has been filed with the SEC. The offering will be made only by means of a prospectus supplement and the accompanying base prospectus. When available, copies of the prospectus supplement and the accompanying prospectus relating to these securities may be obtained from Guggenheim Securities, LLC, 330 Madison Avenue, 8th Floor, New York, NY 10017, Attention: Equity Syndicate Department, by telephone at (212) 518-9349 or by email to [email protected]. Electronic copies of the prospectus supplement and the accompanying prospectus will also be available on the website of the SEC at http://www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy shares of common stock of Biota, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.